Harbor Investment Advisory’s Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share DNA.WS Stock Holding History

Harbor Investment Advisory’s Portfolio DNA.WS Stock Details DNA.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$0	Hold	140	–	–	﹤0.01%	1387
2026 Q1	$0	Hold	140	–	–	﹤0.01%	1374
2025 Q4	$1	Hold	140	–	–	﹤0.01%	1228
2025 Q3	$1	Hold	140	–	–	﹤0.01%	1178
2025 Q2	$2	Hold	140	–	–	﹤0.01%	1172
2025 Q1	$1	Hold	140	–	–	﹤0.01%	1175
2024 Q4	$1	Hold	140	–	–	﹤0.01%	1144
2024 Q3	$1	Hold	140	–	–	﹤0.01%	1150
2024 Q2	$4	Hold	140	–	–	﹤0.01%	1300
2024 Q1	$13	Hold	140	–	–	﹤0.01%	1324
2023 Q4	$15	Hold	140	–	–	﹤0.01%	1150
2023 Q3	$32	Hold	140	–	–	﹤0.01%	1174
2023 Q2	$37	Hold	140	–	–	﹤0.01%	1332
2023 Q1	$25	Hold	140	–	–	﹤0.01%	1319
2022 Q4	$28	Hold	140	–	–	﹤0.01%	1325
2022 Q3	$0	Hold	140	–	–	﹤0.01%	1418
2022 Q2	$0	Hold	140	–	–	﹤0.01%	1428
2022 Q1	$0	Hold	140	–	–	﹤0.01%	1404
2021 Q4	$0	Hold	140	–	–	﹤0.01%	1388
2021 Q3	$0	Buy	+140	New	+$499	﹤0.01%	1367

Harbor Investment Advisory's DNA.WS Position: Q2 2026 in Review

Harbor Investment Advisory held its Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share (DNA.WS) position steady in Q2 2026 at 140 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1387.

Harbor Investment Advisory first reported a position in DNA.WS in Q3 2021 and has held it in 20 quarters since. The position peaked at $37 in Q2 2023. 1 fund tracked by Wall St. Rank holds DNA.WS as of Q2 2026.

Harbor Investment Advisory held 140 shares of Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share worth $0 as of Q2 2026.
Harbor Investment Advisory left its Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share share count unchanged in Q2 2026.
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share made up ﹤0.01% of Harbor Investment Advisory's portfolio in Q2 2026, its #1387 holding.
Harbor Investment Advisory first reported a position in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in Q3 2021 and has held it in 20 quarters since.
Harbor Investment Advisory's Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position peaked at $37 in Q2 2023.
1 fund tracked by Wall St. Rank held Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share as of Q2 2026.

Based on Harbor Investment Advisory's 13F filing for Q2 2026, filed 7 Jul 2026.